SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-225731
Filing Date
2020-08-20
Accepted
2020-08-20 17:15:56
Documents
15
Period of Report
2020-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d811529d8k.htm   iXBRL 8-K 27825
2 EX-10.1 d811529dex101.htm EX-10.1 200846
3 EX-99.1 d811529dex991.htm EX-99.1 12308
7 GRAPHIC g811529g15j14.jpg GRAPHIC 7229
  Complete submission text file 0001193125-20-225731.txt   423495

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cprx-20200814.xsd EX-101.SCH 3088
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20200814_lab.xml EX-101.LAB 18908
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20200814_pre.xml EX-101.PRE 11875
8 EXTRACTED XBRL INSTANCE DOCUMENT d811529d8k_htm.xml XML 3484
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 201120844
SIC: 2834 Pharmaceutical Preparations